Please login to the form below

Not currently logged in
Email:
Password:

chronic pain

This page shows the latest chronic pain news and features for those working in and with pharma, biotech and healthcare.

FDA committee rejects Intellipharmaceutics’ opioid drug Aximris

FDA committee rejects Intellipharmaceutics’ opioid drug Aximris

Aximris was developed as an abuse and alcohol-deterrent controlled-release oral formulation of oxycodone hydrochloride for pain relief. ... Intellipharmaceutics had been seeking approval for the management of pain severe enough to require daily,

Latest news

More from news
Approximately 2 fully matching, plus 101 partially matching documents found.

Latest Intelligence

  • The transatlantic opioid crisis The transatlantic opioid crisis

    The benefits of opioids have been known for centuries. The ancient Greeks and Romans were the first to discover their powerful pain-relieving qualities. ... Workers suffering from chronic pain could be treated more quickly and more cheaply through

  • Tools for the digital world Tools for the digital world

    HealthUnlocked (HU) is one such network, designed to provide patients with a space in which they can discuss symptoms, relief and ways of coping with day-to-day chronic pain.

  • Pursuing better outcomes for people with pain Pursuing better outcomes for people with pain

    Using the patient’s voice to change how we conduct R&D. Pain is a sensation that we have all experienced in one form or another, but chronic pain that limits ... for chronic pain conditions.”.

  • Grünenthal's relentless pursuit of relief Grünenthal's relentless pursuit of relief

    The pursuit of pain relief is nowhere near over and many companies and institutions are chasing answers to reduce the impact of chronic pain and its corrosive byproducts: anxiety, fatigue, depression ... With one in five European adults affected by

  • Deal Watch January 2016 Deal Watch January 2016

    Focusing on development for chronic pain, Quartet will receive a $20m fee (representing the upfront and milestones) to cover development through to phase IIa. ... 150. MannKind/ Receptor Life Sciences. Licence, collaboration. Multiple inhaled therapeutic

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 6 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

How Far Do You Want To Go?
Join OPEN Health's virtual careers event on Tuesday 10th November, 15:00–17:00 GMT and discover where a career in medical communications could take you…...
"Fishbowl" Web Meeting for Internal POA Discussions: a Customer Story
Learn how our client successfully carried out a set of three virtual plan of action (POA) discussions, including one internal “Fishbowl” web meeting....
Whats the difference between patient engagement and patient experience?
We all talk a lot about patient engagement and patient experience. And sometimes, these terms are used interchangeably across the industry. But while they’re both important, they’re not the same....

Infographics